Potential benefits and challenges on the use of phytochemicals for obese COVID-19 patients: A review

Background: COVID-19 produces a great burden on obese individuals. Due to the age-long use of medicinal herbs in the management of obesity, their potential against the COVID-19 pandemic is increasingly investigated. This study aims to review phytochemicals or bioactive compounds with the potential o...

Full description

Saved in:
Bibliographic Details
Main Authors: Murtala Bello Abubakar (Author), Abdurrahman Pharmacy Yusuf (Author), Dawoud Usman (Author), Ibrahim Babangida Abubakar (Author), Babangida Sanusi Katsayal (Author), Idris Zubairu Sadiq (Author), Shehu Muhammad Hassan (Author), Gilead Ebiegberi Forcados (Author), Kasimu Ghandi Ibrahim (Author), Shuaibu Abdullahi Hudu (Author), Aliyu Muhammad (Author)
Format: Book
Published: Elsevier, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_41f7b2f5fd1a4f16a53c64c516e50802
042 |a dc 
100 1 0 |a Murtala Bello Abubakar  |e author 
700 1 0 |a Abdurrahman Pharmacy Yusuf  |e author 
700 1 0 |a Dawoud Usman  |e author 
700 1 0 |a Ibrahim Babangida Abubakar  |e author 
700 1 0 |a Babangida Sanusi Katsayal  |e author 
700 1 0 |a Idris Zubairu Sadiq  |e author 
700 1 0 |a Shehu Muhammad Hassan  |e author 
700 1 0 |a Gilead Ebiegberi Forcados  |e author 
700 1 0 |a Kasimu Ghandi Ibrahim  |e author 
700 1 0 |a Shuaibu Abdullahi Hudu  |e author 
700 1 0 |a Aliyu Muhammad  |e author 
245 0 0 |a Potential benefits and challenges on the use of phytochemicals for obese COVID-19 patients: A review 
260 |b Elsevier,   |c 2024-05-01T00:00:00Z. 
500 |a 2667-0313 
500 |a 10.1016/j.phyplu.2024.100526 
520 |a Background: COVID-19 produces a great burden on obese individuals. Due to the age-long use of medicinal herbs in the management of obesity, their potential against the COVID-19 pandemic is increasingly investigated. This study aims to review phytochemicals or bioactive compounds with the potential of being useful for obese COVID-19 patients. Methods: Using search terms that include pairwise combinations of either COVID-19 or obesity with each of nine selected phytochemicals (epigallocatechin gallate, rutin, astaxanthin, resveratrol, genistein, curcumin, quercetin, ellagic acid, and hesperidin). Relevant articles published from January 2009 to August 2023 were retrieved from PubMed. Results: A total of 43 papers (17 clinical trials, 12 preclinical studies, 3 systemic reviews of randomized controlled trials, and 11 other review papers) met the inclusion criteria and were discussed in this review. These include research articles reporting the anti-COVID-19 properties of the selected phytochemicals, which have previous or recent "clinical evidence" against overweight or obesity Conclusion: Phenolic compounds make up to eight out of the nine selected bioactive compounds and are, therefore, concluded to be the best class of phytochemicals for managing obese COVID-19 patients. 
546 |a EN 
690 |a Ace2 
690 |a Covid-19 
690 |a Herbal medicine 
690 |a Obesity 
690 |a Microbiota 
690 |a Other systems of medicine 
690 |a RZ201-999 
655 7 |a article  |2 local 
786 0 |n Phytomedicine Plus, Vol 4, Iss 2, Pp 100526- (2024) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2667031324000046 
787 0 |n https://doaj.org/toc/2667-0313 
856 4 1 |u https://doaj.org/article/41f7b2f5fd1a4f16a53c64c516e50802  |z Connect to this object online.